Advertisement
Skip to Content

Green Thumb Industries Inc GTBIF Stock Quote

| Rating as of

PINX: GTBIF

Last close prices updated as of Jan 30, 2023, 4:00 PM EST | USD
  • Last Close 7.51
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Small Growth
  • Day Range 7.50  –  7.67
  • Year Range 7.40  –  22.46
  • Market Cap 1.7751 Bil
  • Volume / Avg 1.4 Mil /  559,951.7
  • Price / Sales 1.77
  • Price / Book 1.04
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis GTBIF

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Green Thumb Remains Well Positioned for Expanding Cannabis Legalization Despite Near-Term Challenges

Business Strategy and Outlook

| Kristoffer Inton |

Green Thumb Industries cultivates and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. Unlike its Canadian peers, the firm is more vertically integrated as it owns dispensaries in addition to the cultivation and processing of value-added products. It has a presence in 15 states through 17 production facilities, 77 stores, and six brands. In states with more mature cannabis markets, Green Thumb believes there are enough cultivators available and purchases cannabis from third parties. This helps reduce capital intensity for expansion without sacrificing exposure to widening legalization.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics GTBIF

Company Profile GTBIF

Business Description

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 15 states and operates roughly 75 cannabis stores under the chains Rise and Essence. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including Dr. Solomon’s, Dogwalkers, and Beboe.

Contact
325 West Huron Street, Suite 412
Chicago, IL, 60654
Industry Drug Manufacturers - Specialty & Generic
Employees 3,800

Related Articles GTBIF

FAQs for Green Thumb Industries Inc Stock

No. GTBIF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

GTBIF’s market cap is 1.78 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

GTBIF’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

GTBIF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare GTBIF’s historical performance against its industry peers and the overall market.